#clinical - Techseriesinsight

May 29, 2025
PRNewswire
Biotechnology

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering

Immunic, Inc. (“Immunic” or the “Company”) (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the pricing...

May 28, 2025
PRNewswire
Healthcare

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

Biohaven Ltd. (NYSE: BHVN) (Biohaven), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today...

May 27, 2025
PRNewswire
Biotechnology

KAHR Bio Announces Oral Presentation of Phase 2 Study of DSP107 in Combination with anti-PD-L1 in Colorectal Cancer at 2025 ASCO Annual Meeting

KAHR, a clinical-stage biotech company developing DSP107, a first-in-class bi-specific 4-1BB T-cell engager that activates innate and adaptive immunity to treat solid tumors, today announced that positive results from...

May 26, 2025
PRNewswire
Biotechnology

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical study results of...

May 26, 2025
PRNewswire
Artificial Intelligence

VUNO Showcases DeepCARS® at AACN NTI 2025, Highlighting AI-Driven Cardiac Arrest Risk Prediction

VUNO, a global medical AI company, presented its flagship solution VUNO Med®–DeepCARS® at the 2025 National Teaching Institute & Critical Care Exposition (NTI), hosted by the American Association of Critical-Care...

May 23, 2025
PRNewswire
Healthcare

Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep’s Unique Immune Activation Capabilities

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced new data from the Phase I/II GOBLET clinical trial in a poster presentation...

May 23, 2025
PRNewswire
Biotechnology

SystImmune, Inc. to Present New izalontamab brengitecan (iza-bren) Data in Small Cell Lung Cancer and Non-Small Cell Lung Cancer with Driver Genomic Alterations (GA) outside of Classic EGFR Mutations at ASCO Congress 2025

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that two abstracts on izalontamab brengitecan (iza-bren), a potentially first-in-class EGFRxHER3 bispecific antibody drug conjugate (ADC) will be presented at...

May 21, 2025
PRNewswire
Biotechnology

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it the Supreme Court of Korea has ruled...

May 16, 2025
PRNewswire
Healthcare

Youth To The People Launches Youthscreen–the Brand’s First-Ever SPF

Youth To The People is officially entering its sun care era. The skincare brand known for its superfood-fueled, science-backed formulas is dropping its first-ever sunscreen—and yes, it’s everything consumers have...

May 16, 2025
PRNewswire
Biotechnology

Neutron Therapeutics and Helsinki University Hospital Treat First Head and Neck Cancer Patients Using Accelerator-Based Boron Neutron Capture Therapy

Neutron Therapeutics LLC and the Helsinki University Hospital announce that they have treated the first cancer patients in a European hospital with accelerator-based boron neutron capture therapy (BNCT). This milestone marks...